Considering photodynamic therapy to combat COVID19.
Could photodynamic therapy be a new tool to fight the COVID19 pandemic? Light-based technology can be used to prevent and treat viral infections and is indicated as a method to decontaminate humans that have already received exposure to biological agents, without causing undue harm to host tissue.
When we consider the apparent seasonal differences in the recent COVID19 spread throughout the global hemisphere and the global possibility of viral transmission throughout the world as a result of international travel and globalisation, the apparent low infection rate in the southern hemisphere with apparent seasonal influence on COVID19 spread may be explained by the atmospheric UV levels in those regions. Currently the UK has UV index of 1-2 and Australia has a UV index of 5-12, South Africa maximum 12, several times that of the UK. Seasonal flu epidemics in the Middle East occur at relatively high global temperatures but reduced UV indexes, indicating that UV levels may be a factor in these seasonal epidemics.
Germicidal UV (UVC) light from monochromatic or polychromatic light sources destroys many viruses and research data suggests that UVC has a high selectivity over host mammalian cells and tissues. Further Near Infra Red (NIR) has been shown to cause damage to the protein coat of a virus or bacteria, thus inactivating it using NIR femtosecond laser. This process targets the mechanical or vibrational properties of microorganisms.
If low-level UV emitters from light sources equivalent to safe summer values were placed in public places or where people frequent could this affect the transmission of the virus in the most affected countries?
Light is non-polluting and environmentally friendly, and when containment of the virus is accomplished and the bio-threat has been neutralized photodynamic means will leave no lasting pollution or drug reactions.
Using a very low power visible femtosecond laser to selectively inactivate viruses and other microorganisms has been found to leave sensitive materials unharmed by manipulating and controlling with the femtosecond laser system in experiments.
Obviously, consideration should be made for individuals as UV light is a mutagen to microbes and humans alike and people who are susceptible to UV DNA damage (eg P53 mutations, Li–Fraumeni) should be warned about exposure but if levels are well within safe values similar to safe levels of natural sunlight exposure for unaffected individuals then clearly this is a strategy well worth considering in countries affected by the COVID19 virus. Antimicrobial germicidal sterilisation lamps are already available commercially to effectively inactivate viruses.
References
McDevitt JJ, Milton DK, Rudnick SN, First MW. Inactivation of poxviruses by upper-room UVC light in a simulated hospital room environment. PLoS One. 2008;3:e3186. doi: 10.1371/journal.pone.0003186.
Sagripanti JL, Lytle CD. Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces. Arch Virol. 2011;156:489–94.
Fatma Vatansever, Cleber Ferraresi, Marcelo Victor Pires de Sousa, Rui Yin, Ardeshir Rineh, Sulbha K Sharma, and Michael R Hamblin, Can biowarfare agents be defeated with light? Virulence. 2013 Nov 15; 4(8): 796–825.
Dai T, Vrahas MS, Murray CK, Hamblin MR. Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Expert Rev Anti Infect Ther. 2012;10:185–95. doi: 10.1586/eri.11.166
Pinna D, Sampson-Johannes A, Clementi M, Poli G, Rossini S, Lin L, Vicenzi E. Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates. Transfus Med. 2005;15:269–76. doi: 10.1111/j.0958-7578.2005.00588.x.
Costa L, Faustino MA, Neves MG, Cunha A, Almeida A. Photodynamic inactivation of mammalian viruses and bacteriophages. Viruses. 2012;4:1034–74. doi: 10.3390/v4071034.
Tsen K, Tsen S, Chang C, Hung C, Wu T, Kiang J. Inactivation of viruses with a very low power visible femtosecond laser. J Phys Condens Matter. 2007;19:322102. doi: 10.1088/0953-8984/19/32/322102